Ting-Ting Tang1,2,†, Yuan-Yuan Li1,2,†, Jing-Jing Li1,2,†, Ke Wang1,2,†, Yue Han1,2, Wen-Yong Dong1,2, Zheng-Feng Zhu1,2, Ni Xia1,2, Shao-Fang Nie1,2, Min Zhang1,2, Zhi-Peng Zeng1,2, Bing-Jie Lv1,2, Jiao Jiao1,2, Heng Liu3, Zong-Shu Xian3, Xiang-Ping Yang4, Yu Hu5,6, Yu-Hua Liao1,2, Qing Wang7, Xin Tu7, Ziad Mallat8, Yu Huang9, Guo-Ping Shi10, Xiang Cheng1,2✉
1. Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
2. Key Laboratory of Biological Targeted Therapy of the Ministry of Education, Wuhan 430022, China
3. Generon Corporation, Building 9, 720 Cai Lun Road, Zhang Jiang Hi-Tech Park, Shanghai 201203, China
4. Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
5. Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430022, China
6. Targeted Biotherapy Key Laboratory of Ministry of Education, Wuhan 430022, China
7. Key Laboratory of Molecular Biophysics of the Ministry of Education, Cardio-X Institute, College of Life Science and Technology and Center of Human Genome Research, Huazhong University of Science and Technology, Wuhan 430074, China
8. Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, CB20 SZ, UK
9. Institute of Vascular Medicine and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong, China
10. Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA
† These authors contributed equally to this study.
